These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 36725865)
1. Controlled human drug administration studies are necessary to define the THC-sparing effects of CBD and other cannabis constituents. Pabon E; Cooper ZD Neuropsychopharmacology; 2023 May; 48(6):850-851. PubMed ID: 36725865 [No Abstract] [Full Text] [Related]
2. Individual and combined effects of cannabidiol and Δ Wall MB; Freeman TP; Hindocha C; Demetriou L; Ertl N; Freeman AM; Jones AP; Lawn W; Pope R; Mokrysz C; Solomons D; Statton B; Walker HR; Yamamori Y; Yang Z; Yim JL; Nutt DJ; Howes OD; Curran HV; Bloomfield MA J Psychopharmacol; 2022 Jun; 36(6):732-744. PubMed ID: 35596578 [TBL] [Abstract][Full Text] [Related]
3. Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis. Hutten NRPW; Arkell TR; Vinckenbosch F; Schepers J; Kevin RC; Theunissen EL; Kuypers KPC; McGregor IS; Ramaekers JG Psychopharmacology (Berl); 2022 Nov; 239(11):3731-3741. PubMed ID: 36227352 [TBL] [Abstract][Full Text] [Related]
4. Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios. Englund A; Oliver D; Chesney E; Chester L; Wilson J; Sovi S; De Micheli A; Hodsoll J; Fusar-Poli P; Strang J; Murray RM; Freeman TP; McGuire P Neuropsychopharmacology; 2023 May; 48(6):869-876. PubMed ID: 36380220 [TBL] [Abstract][Full Text] [Related]
5. Cannabinoid use is enhanced by stress and changes conditioned stress responses. Hodebourg R; Meyerink ME; Crow AD; Reichel CM; Kalivas PW; Garcia-Keller C Neuropsychopharmacology; 2022 Apr; 47(5):1037-1045. PubMed ID: 35145212 [TBL] [Abstract][Full Text] [Related]
6. Dissociable effects of cannabis with and without cannabidiol on the human brain's resting-state functional connectivity. Wall MB; Pope R; Freeman TP; Kowalczyk OS; Demetriou L; Mokrysz C; Hindocha C; Lawn W; Bloomfield MA; Freeman AM; Feilding A; Nutt D; Curran HV J Psychopharmacol; 2019 Jul; 33(7):822-830. PubMed ID: 31013455 [TBL] [Abstract][Full Text] [Related]
7. Effects of oral Δ9-tetrahydrocannabinol and cannabidiol combinations on a sustained attention task in rats. Moore CF; Davis CM; Sempio C; Klawitter J; Christians U; Weerts EM Exp Clin Psychopharmacol; 2023 Oct; 31(5):881-887. PubMed ID: 36634015 [TBL] [Abstract][Full Text] [Related]
8. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990 [TBL] [Abstract][Full Text] [Related]
10. Translational models of cannabinoid vapor exposure in laboratory animals. Moore CF; Stiltner JW; Davis CM; Weerts EM Behav Pharmacol; 2022 Apr; 33(2&3):63-89. PubMed ID: 33136615 [TBL] [Abstract][Full Text] [Related]
11. Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses. Lawn W; Freeman TP; Pope RA; Joye A; Harvey L; Hindocha C; Mokrysz C; Moss A; Wall MB; Bloomfield MA; Das RK; Morgan CJ; Nutt DJ; Curran HV Psychopharmacology (Berl); 2016 Oct; 233(19-20):3537-52. PubMed ID: 27585792 [TBL] [Abstract][Full Text] [Related]
12. Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme. Hindocha C; Freeman TP; Schafer G; Gardner C; Bloomfield MAP; Bramon E; Morgan CJA; Curran HV Addict Biol; 2020 May; 25(3):e12762. PubMed ID: 31013550 [TBL] [Abstract][Full Text] [Related]
13. THC and CBD: Villain versus Hero? Insights into Adolescent Exposure. Pintori N; Caria F; De Luca MA; Miliano C Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982327 [TBL] [Abstract][Full Text] [Related]
14. Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function. Morgan CJA; Freeman TP; Hindocha C; Schafer G; Gardner C; Curran HV Transl Psychiatry; 2018 Sep; 8(1):181. PubMed ID: 30185793 [TBL] [Abstract][Full Text] [Related]
15. A randomised controlled trial of vaporised Δ Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105 [TBL] [Abstract][Full Text] [Related]
16. Perceptions about THC and CBD effects among adults with and without prior cannabis experience. Spinella TC; Bartholomeusz J; Stewart SH; Barrett SP Addict Behav; 2023 Feb; 137():107508. PubMed ID: 36270038 [TBL] [Abstract][Full Text] [Related]
17. Effect of Delta-9-tetrahydrocannabinol and cannabidiol on milk proteins and lipid levels in HC11 cells. Josan C; Podinic T; Pfaff N; Raha S PLoS One; 2022; 17(8):e0272819. PubMed ID: 35976913 [TBL] [Abstract][Full Text] [Related]
18. Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study. Sainz-Cort A; Jimenez-Garrido D; Muñoz-Marron E; Viejo-Sobera R; Heeroma J; Bouso JC J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):561-570. PubMed ID: 34412109 [TBL] [Abstract][Full Text] [Related]
19. Acute effects of Δ Greenwood LM; Broyd SJ; van Hell HH; Todd J; Jones A; Murray RM; Croft RJ; Michie PT; Solowij N Psychopharmacology (Berl); 2022 May; 239(5):1409-1424. PubMed ID: 34719731 [TBL] [Abstract][Full Text] [Related]
20. Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model. Casey SL; Mitchell VA; Sokolaj EE; Winters BL; Vaughan CW Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]